Adults with type 2 diabetes and a moderate or high risk of CVD were less likely to experience a serious cardiovascular event ...
While aspirin has been shown to be effective in reducing the risk of cardiovascular events, there have previously been no dosage recommendations tailored to a person's weight. But a new study ...
Please provide your email address to receive an email when new articles are posted on . Among patients with atherosclerotic CVD, there was no difference in CV events or major bleeding according to ...
The Healthy @Reader's Digest on MSN
Study: Low-Dose Aspirin Could Lower Heart Risk in People With This Condition
Leading heart experts say the results were "somewhat surprising," and their discovery could warrant a conversation with your doctor.
(UPDATED) Treating patients with atherosclerotic cardiovascular disease (ASCVD) with low-dose aspirin is just as effective as using the 325-mg dose for the prevention of major cardiovascular events, ...
Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...
A recent article posted in the Journal of the American Medical Association (JAMA) analyzed aspirin use to prevent cardiovascular disease (CVD) and colorectal cancer (CRC). Report: Aspirin Use to ...
11don MSN
Aspirin can prevent a serious pregnancy complication — but too few women get it, new report suggests
Pre-eclampsia, a condition that causes dangerously high blood pressure, is a leading cause of death among mothers and babies.
Each year, about 1 in 25 pregnancies in the United States is affected by preeclampsia, a dangerous condition marked by high blood pressure and other complications. A diagnosis can turn what should be ...
Aspirin is a common over-the-counter medication for pain relief, fever reduction, and inflammation. While it’s a safe and effective medication when used as directed, taking too many aspirin pills can ...
Cerenis Therapeutics SA, a biotech startup based in Toulouse, France with laboratory operations in Ann Arbor, said Monday it will present the results of two clinical proof-of-concept studies for its ...
Stage 1 PV management includes phlebotomy, low-dose aspirin, cytoreductive therapy, and lifestyle changes to prevent complications. Stage 1 polycythemia vera is manageable with monitoring, phlebotomy, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results